Hongri Pharmaceutical: Summary table of the company\'s non-operating capital occupation and other related capital transactions for the first half year of 2024
Hongri Pharmaceutical: Prompt Announcement on the Disclosure of the 2024 Semi-Annual Report
Hongri Pharmaceutical: Announcement on the Company\'s Factoring of Accounts Receivable Business
Hongri Pharmaceutical: Announcement of Joint Credit Assessment Co., Ltd. on terminating the credit ratings of the principal and related debts of Tianjin Hongri Pharmaceutical Co., Ltd.
Tianjin Chase Sun Pharmaceutical: Announcement Regarding the Approval of the Company's Application for Listing of Active Pharmaceutical Ingredient
Tianjin Chase Sun Pharmaceutical: The third reminder announcement of Tianjin Chase Sun Pharmaceutical Co., Ltd. regarding the adjustment of the coupon rate of "21 Red Sun 01" and the implementation of bond repurchase by holders.
Tianjin Chase Sun Pharmaceutical: The second reminder announcement of Tianjin Chase Sun Pharmaceutical Co., Ltd. regarding the adjustment of the coupon rate of "21 Red Sun 01" and the implementation of bond holder's put option.
Tianjin Chase Sun Pharmaceutical: The first indicative announcement of Tianjin Chase Sun Pharmaceutical Co., Ltd. regarding the adjustment of the coupon rate and the implementation method of bond holders' right to sell back for "21 Red Sun 01" bonds.
Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report Disclosure Prompt Announcement
Hongri Pharmaceutical: Notice on the Company's Completion of the Registration of the Legal Representative's Change of Trade
Hongri Pharmaceutical: Legal Opinion of the 2023 Annual General Meeting of Shareholders
Hongri Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Hongri Pharmaceutical: Legal Opinion of the Third Extraordinary General Meeting of Shareholders in 2024
Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: Interim Report of Tianfeng Securities Co., Ltd. on the fiduciary management matters of the resignation of the chairman of Tianjin Hongri Pharmaceutical Co., Ltd. and the by-election of directors, chairman, vice chairman, adjustment o
Hongri Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Hongri Pharmaceutical: Announcement on the Resignation of the Chairman of the Company and the By-election of Directors, Chairman of the Board, Vice Chairman, Adjustment of Special Committee Members, Changes in Legal Representatives, and Appointment of Comp
Hongri Pharmaceutical: Legal Opinion of the 2024 Second Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Hongri Pharmaceutical: 2023 Annual Financial Report
No Data
No Data